IgE Depletion With Ligelizumab Does Not Significantly Improve Clinical Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis.
The Journal of investigative dermatology
View this publicationThe Journal of investigative dermatology
View this publicationAllergy
View this publicationClinical and translational allergy
View this publicationAllergy
View this publicationAllergy
View this publicationThe British journal of dermatology
View this publicationThe Journal of allergy and clinical immunology
View this publicationInternational reviews of immunology
View this publicationAllergo journal international
View this publicationVaccines
View this publication